Table 1.
Patient demographics and disease characteristics at presentation (institutional data)
Stenting cohort (n = 12) | Colostomy cohort (n = 24) | p Value | |
---|---|---|---|
Mean age (year) | 67.08 | 58.25 | 0.052 |
Gender (% female) | 50 | 54.1 | 0.813 |
Race (% African American) | 33.33 | 45.83 | 0.469 |
Cancer site: n (%) | 1.000 | ||
Sigmoid | 9 (75) | 18 (75) | |
Rectum | 2 (17) | 4 (17) | |
Transverse | 1 (8) | 2 (8) | |
Histology: n (%) (adenocarcinoma) | 12 (100) | 24 (100) | 1.000 |
Stage: n (%) | 0.655 | ||
2 | 2 (17) | 4 (17) | |
3 | 1 (8) | 5 (21) | |
4 | 9 (75) | 15 (62) | |
Metastasis: n (%) | 10 (83) | 15 (63) | 0.186 |
Mean albumin (mg/dl) | 3.10 | 2.69 | 0.212 |
Mean Charlson’s score | 6.08 | 5.54 | 0.426 |